The role of AI should be primarily focused on helping people and providing better outcomes in healthcare.
In this episode, Mike Montello, Senior Vice President of R&D and Digital and Technology at GSK explains the role of AI in driving drug discovery through genetics and genomics. He highlights AI's impact on clinical trial acceleration and cost reduction, highlighting the importance of transformation and acceleration for pharma companies.
Mike shares the criteria a quality startup must meet to collaborate with GSK, such as aligning with their priorities, and puts more focus on what technology can do for people than the other way around. Finally, Mike expresses his admiration for leaders such as Simon Sinek and Brené Brown, who inspire and motivate his efforts.
__
Listen in www.hlth.com/digital-content/hlth-matters/podcast/…
HLTH